Literature DB >> 9864740

Direct ethanol injection for skull metastasis from hepatocellular carcinoma. The techniques and consequences of a therapeutic trial.

T Isaka1, T Yoshimine, K Fujimoto, M Masuzawa, M Maruno, T Hayakawa, S Nakatani.   

Abstract

The frequency of skull metastasis from hepatocellular carcinoma (HCC) is increasing together with the recent progress in the management of the primary lesion. Cases are often complicated with poor general conditions or metastasis to the other organs, and not readily indicated for surgery. A direct injection of ethanol to the lesion could be one of the therapeutic options to cope with this complicated situation. To evaluate the feasibility of this technique, we planned a therapeutic trial in a patient with HCC associated with lumbar and skull metastasis, the latter metastasis repeated twice during the past one year. A total of 10 ml of ethanol was injected into the skull metastasis percutaneously under ultrasound (US) guidance. US guidance was very useful in determining the sites of injections and the distribution of ethanol as well as monitoring the blood flow within the tumor vessels. The patient transiently complained of local pain at the injection sites, but there were no other adverse effects. Four days after the injection, the lesion was resected by surgery, which confirmed the pathologic diagnosis as well as the nearly-total necrosis of the tumor. This technique is simple, safe and repeatable with low cost. The technical details and the histologic effects are described.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9864740     DOI: 10.1080/01616412.1998.11740593

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  2 in total

1.  Successful removal of a giant skull base metastasis from hepatocellular carcinoma after direct ethanol injection: case report.

Authors:  T Isaka; H Nakagawa; T Suzuki; J Yamada; K Wada; T Kadota
Journal:  Skull Base Surg       Date:  2000

2.  Skull metastasis from hepatocellular carcinoma with chronic hepatitis B.

Authors:  Takashi Goto; Takahiro Dohmen; Kouichi Miura; Shigetoshi Ohshima; Kazuo Yoneyama; Tomomi Shibuya; Ei Kataoka; Daisuke Segawa; Wataru Sato; Yumiko Anezaki; Hajime Ishii; Daigo Kon; Ikuhiro Yamada; Kentaro Kamada; Hirohide Ohnishi
Journal:  World J Gastrointest Oncol       Date:  2010-03-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.